Evidence map›Paper›PMID 33523960›Full record

ArticleScience advances2021

Adiponectin receptor 1 variants contribute to hypertrophic cardiomyopathy that can be reversed by rapamycin.

Perundurai S Dhandapany, Soojeong Kang, Deepak K Kashyap, Raksha Rajagopal, Nagalingam R Sundaresan, Rajvir Singh, Kumarasamy Thangaraj, Shilpa Jayaprakash, Cholenahally N Manjunath, Jayaprakash Shenthar and 1 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Perundurai S DhandapanyCentre for Cardiovascular Biology and Disease, Institute for Stem Cell Science and Regenerative Medicine (inStem), Bangalore, India. dhan@instem.res.in djamel.lebeche@mssm.edu.ORCID 0000-0001-7831-9570
Soojeong KangCardiovascular Research Center, Department of Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA.ORCID 0000-0001-5658-4955
Deepak K KashyapCentre for Cardiovascular Biology and Disease, Institute for Stem Cell Science and Regenerative Medicine (inStem), Bangalore, India.ORCID 0000-0001-5352-0040
Raksha RajagopalDepartment of Microbiology and Cell Biology, Indian Institute of Science, CV Raman Avenue, Bangalore, India.ORCID 0000-0002-0580-6236
Nagalingam R SundaresanDepartment of Microbiology and Cell Biology, Indian Institute of Science, CV Raman Avenue, Bangalore, India.
Rajvir SinghCardiovascular Research Center, Department of Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA.
Kumarasamy ThangarajCSIR-Center for Cellular and Molecular Biology, Hyderabad, India.ORCID 0000-0002-0075-0106
Shilpa JayaprakashDepartment of Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, India.
Cholenahally N ManjunathDepartment of Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, India.
Jayaprakash ShentharDepartment of Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, India.
Djamel LebecheCardiovascular Research Center, Department of Medicine, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029, USA. dhan@instem.res.in djamel.lebeche@mssm.edu.ORCID 0000-0002-7911-2923
Icahn School of Medicine at Mount Sinai · USSri Jayadeva Institute of Cardiovascular Sciences and Research · INCentre for Cellular and Molecular Biology · INIndian Institute of Science Bangalore · INOregon Health & Science University · US

Funding

TRAINING PROGRAM IN MOLECULAR AND CELLULAR CARDIOLOGYT32HL007824 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GELB, BRUCE D · 1995 to 2022
$8.6M
Molecular and Metabolic phenotype of Impaired AdipoR1 in the HeartR01HL137220 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LEBECHE, DJAMEL · 2017 to 2020
$1.7M
DBT-Wellcome Trust India Alliance IA/I/16/1/502367NHLBI NIH HHS R01 HL137220NHLBI NIH HHS T32 HL007824Wellcome Trust
6 · The paper itself

Abstract

Hypertrophic cardiomyopathy (HCM) is a heterogeneous genetic heart muscle disease characterized by hypertrophy with preserved or increased ejection fraction in the absence of secondary causes. However, recent studies have demonstrated that a substantial proportion of individuals with HCM also have comorbid diabetes mellitus (~10%). Whether genetic variants may contribute a combined phenotype of HCM and diabetes mellitus is not known. Here, using next-generation sequencing methods, we identified novel and ultrarare variants in adiponectin receptor 1 (

Identifiers

PMID33523960
PMCPMC7787482
OpenAlexW3119916756

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.